Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine…
In Conversation
SinoGenoMax was founded in 1998 with the purpose of participating in the Human Genome Project. Could you give us an overview of the company’s activities since…
You have a long experience in the Chinese pharmaceutical market, and in particular you saw it evolve tremendously over the last 10 years. From a management…
We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves” – that of all people with diabetes, 50% of…
You completed your higher education in the US and worked there for a period afterwards; what caused you to move back to China and start this…
You have very successfully executed a vision that you have had for the company since it was a 200 Rs Cr turnover, India-focused enterprise 15 years…
Dr Ammelburg, you have been working for Roche for more than 25 years now, time essentially spent between your home country Germany and Thailand. After more…
When Astellas announced to expand its presence in India in 2009, you were already speaking of the company’s long commitment and solid relationship with India. Can…
Cheng-Ho Tsai, Mackay Memorial Hospital has a unique background and origins. How has this endured through the different stages of the pharmaceutical sector in Taiwan, and…
Academia Sinica celebrated its 80th anniversary in 2008. After this milestone, how does the institute define its activities today? Academia Sinica was founded more than eighty…
Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research business, and is somewhat unique,…
You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are according to…
